-
Symbol
-
XLO on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.0001 per share
-
Latest Disclosed Ownership
-
4.35M shares
-
Security Ownership
-
9%
AbbVie Inc. ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)
2025-02-18 - AbbVie Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.35M shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO).
This represents 9% percent ownership of the company.